Coronavirus (COVID-19): visiting The Royal Marsden suspended

Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.

Cancer Genetics Unit

The Cancer Genetics Unit offers services to patients of The Royal Marsden and their families who are concerned about a risk of inherited cancer

Our services include, where appropriate:

  • Familial cancer risk assessment
  • Diagnostic genetic testing (testing of one or more genes known to associated with cancer predisposition)
  • Predictive genetic testing (testing for a specific mutation in a gene, already identified within a family)
  • Advice and referral for cancer screening
  • Discussion of cancer risk-reducing management options
  • Assistance with decisions on cancer treatment options
  • Offer of enrolment in genetic research studies
  • Long term open access follow up for patients with a known gene mutation on the RM Carrier Register
Our aim is to promote cancer prevention, early detection and to help in some cases with management decisions. We assess personal and family history of cancer to decide whether it is likely that there is a hereditary cause. We use this assessment to decide whether a genetic test might help an individual to clarify their own risk.
 
We advise on cancer screening for family members and discuss options for reducing cancer risk. We work closely with our colleagyes in the Breast and Gynaecololgy units to enable some cancer patients to have genetic testing through their Oncology teams. 

Consultants:

  • Dr Angela George (Gynaecology and Genetics)
  • Dr Zoe Kemp (Breast and Genetics)
  • Dr Rosalind Eeles (Urology and Genetics)
  • Dr Terri McVeigh , Consultant Clinical Geneticist
  • Professor Richard Houlston (ICR) 

Downloads